Artivion (AORT) Asset Writedowns and Impairment (2010 - 2013)
Artivion posted quarterly Asset Writedowns and Impairment of $3.2 million for Q4 2013, up 841.18% on a QoQ basis from $340000.0 in Q3 2012.
Artivion (AORT) has 3 years of Asset Writedowns and Impairment data on file, last reported at $3.2 million in Q4 2013.
- For the quarter ending Q4 2013, Asset Writedowns and Impairment changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2013 stood at $4.5 million (changed N/A YoY), and the FY2021 full-year result was $4.9 million, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q4 2013 stood at $3.2 million, up from $340000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $3.6 million in Q3 2010 and bottomed at -$2.7 million in Q4 2010.
- The 3-year median for Asset Writedowns and Impairment is $1.8 million (2012), against an average of $1.1 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 3.20 Mn |
| Dec 31, 2013 | 3.20 Mn |
| Sep 30, 2012 | 340,000.00 |
| Sep 30, 2012 | 340,000.00 |
| Dec 31, 2010 | -2.72 Mn |
| Dec 31, 2010 | -2.72 Mn |
| Sep 30, 2010 | 3.64 Mn |
| Sep 30, 2010 | 3.64 Mn |